Open-heart surgery requires temporarily stopping the heart and lungs and diverting the patient's blood to an outside system that takes over the function of the heart and lungs. This is possible through the use of cardiopulmonary bypass (CPB) which diverts blood, through plastic tubing, to a heart-lung machine which includes an oxygenator. The external oxygenator works as an artificial lung. This allows cardiac surgeons to operate in a field that is free of blood, while the patient's body continues to receive healthy blood. CPB is an advanced medical technology that allows for heart surgeries, such as coronary artery bypass, heart valve surgery, and procedures involving major blood vessels. It is recognized that there are many risks associated with its use, including microscopic stress exerted on blood components by the oxygenator and tubing, which can lead to irreversible damage to the blood cells. This effect can contribute to bleeding during and after surgery. This type of bleeding can be difficult to monitor and treat, especially given the limited access to point-of-care blood testing to inform clinicians on what part of the blood is failing to function properly. The investigators will use a point-of-care machine called Plateletworks to test the function of platelets during surgeries which require CPB. Platelets are an important part of blood that help stop bleeding by forming clots. At the investigators' institution two oxygenators are currently used interchangeably. These oxygenators have different properties that may impact how platelets function. This project will help determine if using a higher pressure oxygenator increases the risk of patients bleeding. Additionally, the investigators will compare the platelet data from Plateletworks to data collected from rotational thromboelastometry (ROTEM). This will yield valuable data about commonly used oxygenators and tests which can ultimately improve patient care.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
70
Halifax Infirmary site, Queen Elizabeth II Health Sciences Centre
Halifax, Nova Scotia, Canada
RECRUITINGPlateletworks change in functional platelets
Change in functional platelets during cardiopulmonary bypass as measure by Plateletworks. ((Functional Platelets start - Functional Platelets end) / Functional Platelets start) \*100%.
Time frame: 24 hours from start of surgery (measured at the start and the end of cardiopulmonary bypass)
Plateletworks functional platelet count
Functional platelet count at the end of cardiopulmonary bypass as measured by Plateletworks.
Time frame: 24 hours from start of surgery (measured at the end of cardiopulmonary bypass)
Percentage of platelets which are functional at the end of cardiopulmonary bypass
Percentage of platelets which are functional at the end of cardiopulmonary bypass as measured by Plateletworks.
Time frame: 24 hours from start of surgery (measured at the end of cardiopulmonary bypass)
ROTEM change in functional platelets
ROTEM platelet function = EXTEM A10 - FIBTEM A10. ROTEM change in functional platelets = ((ROTEM Functional Platelets start - ROTEM Functional Platelets end) / ROTEM Functional Platelets start) \*100%.
Time frame: 24 hours from start of surgery (measured at the start and the end of cardiopulmonary bypass)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.